1. Downregulation of the Coiled-Coil Domain Containing 80 and Its Perspective Mechanisms in Ovarian Carcinoma: A Comprehensive Study
   Zi-Qian Liang et al, 2021, International Journal of Genomics CrossRef
2. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells
   Yuri Lee et al, 2022, Cancers CrossRef
3. POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1
   Peng Zhang et al, 2022, Cell Death & Disease CrossRef
4. FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
   Cassie Liu et al, 2021, Cancers CrossRef
5. Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
   Xiaoyi Hu et al, 2022, Frontiers in Immunology CrossRef
6. The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications
   Christian Bailly, 2022, European Journal of Pharmacology CrossRef
7. Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
   Sanjeev Raghuwanshi et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
8. Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
   Kanae Akita et al, 2021, Frontiers in Immunology CrossRef
9. Abnormal expression of FOXM1 in carcinogenesis of renal cell carcinoma: From experimental findings to clinical applications
   Yanmei Shan et al, 2024, Biochemical and Biophysical Research Communications CrossRef